English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Transcenta
Patient Daily
| May 4, 2023
Completion of Enrollment in Cohorts C and G of China Phase II Clinical Study of Osemitamab (TST001) in Combination with CAPOX with or without Nivolumab as First-line Treatment of Gastric/Gastro-esophageal Junction Cancer Patients
Patient Daily
| Apr 21, 2023
Transcenta Presents Two Preclinical Studies at AACR 2023
Trending
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
American Lung Association launches campaign for World Bronchiectasis Day
+
Pharmaceuticals
Patient Daily
| Jul 2, 2025
Mutations in blood stem cells may reduce Alzheimer's risk
